An association between methamphetamine use and a skin infection should not automatically be explained as infection introduced by a needle. A rural Georgia investigation published in 2007 found an association with MRSA, but injection was uncommon among its small number of methamphetamine-using MRSA cases. The route data materially change what can be claimed about the mechanism.
What did the investigators compare?
Cohen and colleagues enrolled patients at six emergency or urgent-care sites during September–October 2005. They identified 81 culture-confirmed MRSA skin and soft-tissue infections among 119 infections. Eight of 81 MRSA patients reported methamphetamine use in the preceding three months, compared with five of 283 controls with available exposure data.
Those are selected clinical groups. The proportion of infections growing MRSA is not the proportion of methamphetamine users who develop MRSA. The control denominator also needs to follow the exposure question’s available data, rather than being replaced automatically with the full enrolled control count.
What did the association mean?
The methamphetamine association had an adjusted odds ratio of 5.10, with a 95% confidence interval of 1.55–16.79, accounting for age, sex and race and stratifying by site. Use was self-reported, without toxicological confirmation.
This estimate compares exposure odds within the case–control design. It is not a finding that every user faces a 5.10-fold absolute probability of infection. The wide interval is also relevant: the direction of the observed association does not supply a precise measure of its size. Adjustment for several variables does not isolate every correlated behavior or living condition.
Which routes were reported?
Among the eight methamphetamine-using MRSA patients, five reported smoking or inhalation, one injection and one oral use; one route was unknown. The same common community MRSA strain types appeared in users and nonusers. The investigation did not test whether methamphetamine or equipment was contaminated.
These observations challenge a needle-only explanation for the association. They do not prove that inhaled methamphetamine directly transmitted bacteria, chemically damaged skin or caused an immune defect. A route of drug administration and a route of bacterial transmission are separate questions. Knowing the former does not automatically answer the latter.
Can strain similarity establish who infected whom?
Finding related strains in different groups can support investigating a shared transmission environment. It cannot, without sufficient contact and timing evidence, establish a particular transmission chain. The presence of a common community strain makes a unique drug-associated organism explanation less persuasive; it does not identify an individual source.
Clinical selection and self-reported exposure also limit generalization. This investigation sampled people seeking care in particular communities during a short historical interval. Its data should not be presented as a current national MRSA prevalence estimate or a contemporary antibiotic-selection guide.
What makes a defensible case-specific account?
Start with the culture result, anatomical infection, exposure history and actual route information. Then assess the proposed connection: direct inoculation, contact transmission, skin injury or another pathway. Identify which links are documented and which remain hypotheses.
The study’s practical contribution is that methamphetamine-associated MRSA cannot be reduced to injection alone. It supports a broader investigation while leaving the cause and transmission route of an individual infection to the available clinical and exposure record.
Source
Cohen AL et al. Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections. Emerging Infectious Diseases. 2007;13(11):1707–1713. doi:10.3201/eid1311.070148. Full text. Historical human case–control investigation.